Gilead Sciences Inc.

NAS: GILD

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Gilead Sciences Inc.

Before the Bell

--Quotes are delayed by 20 min

Mar 28, 2023, 8:02 a.m.

GILD

/zigman2/quotes/210293917/composite

79.58

Change

0.00 0.00%

Volume

Volume 546

Quotes are delayed by 20 min

/zigman2/quotes/210293917/composite

Previous close

$ 79.58

Change

-0.42 -0.53%

Day low

Day high

$79.41

$80.99

52 week low

52 week high

$57.17

$89.74

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Gilead Sciences Inc.

View Ratios

Fiscal year is January-December. All values USD millions.	2018	2019	2020	2021	2022	5-year trend
Sales/Revenue	22.21B	22.32B	24.64B	27.37B	27.09B
Sales Growth	-	0.49%	10.39%	11.08%	-1.05%
Cost of Goods Sold (COGS) incl. D&A	4.85B	4.68B	4.51B	6.6B	5.66B
COGS excluding D&A	3.42B	3.27B	3.03B	4.55B	3.55B
Depreciation & Amortization Expense	1.43B	1.4B	1.48B	2.05B	2.1B
Depreciation	226M	255M	288M	329M	323M
Amortization of Intangibles	1.2B	1.15B	1.19B	1.72B	1.78B
COGS Growth	-	-3.67%	-3.55%	46.40%	-14.30%
Gross Income	17.36B	17.65B	20.13B	20.77B	21.43B
Gross Income Growth	-	1.65%	14.09%	3.17%	3.16%
Gross Profit Margin	-	-	-	-	79.11%	NA

	2018	2019	2020	2021	2022	5-year trend
SG&A Expense	8.25B	12.69B	9.69B	10.57B	10.67B
Research & Development	4.2B	8.31B	4.86B	5.36B	5B
Other SG&A	4.06B	4.38B	4.83B	5.21B	5.67B
SGA Growth	-	53.71%	-23.63%	9.09%	0.96%
Other Operating Expense	-	-	-	-	-
Unusual Expense	707M	(422M)	2.94B	1.52B	4.21B
EBIT after Unusual Expense	8.4B	5.38B	7.5B	8.68B	6.54B
Non Operating Income/Expense	476M	773M	(4.85B)	600M	205M
Non-Operating Interest Income	-	-	-	-	-
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	1.08B	995M	984M	1B	935M
Interest Expense Growth	-	-7.61%	-1.11%	1.73%	-6.59%
Gross Interest Expense	1.08B	995M	984M	1B	935M
Interest Capitalized	-	-	-	-	-
Pretax Income	7.8B	5.16B	1.67B	8.28B	5.81B
Pretax Income Growth	-	-33.84%	-67.66%	395.99%	-29.77%
Pretax Margin	-	-	-	-	21.47%	NA
Income Tax	2.34B	(204M)	1.58B	2.08B	1.25B
Income Tax - Current Domestic	1.88B	1.78B	1.65B	2B	2.57B
Income Tax - Current Foreign	175M	124M	155M	185M	232M
Income Tax - Deferred Domestic	307M	(885M)	(261M)	(65M)	(1.66B)
Income Tax - Deferred Foreign	(21M)	(1.22B)	38M	(47M)	101M
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	-	-	-	-
Consolidated Net Income	5.46B	5.36B	89M	6.2B	4.57B
Minority Interest Expense	5M	(22M)	(34M)	(24M)	(26M)
Net Income	5.46B	5.39B	123M	6.23B	4.59B
Net Income Growth	-	-1.26%	-97.72%	4,960.98%	-26.23%
Net Margin Growth	-	-	-	-	16.95%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	5.46B	5.39B	123M	6.23B	4.59B
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	5.46B	5.39B	123M	6.23B	4.59B
EPS (Basic)	4.20	4.24	0.10	4.96	3.66
EPS (Basic) Growth	-	0.91%	-97.69%	4,962.51%	-26.17%
Basic Shares Outstanding	1.3B	1.27B	1.26B	1.26B	1.26B
EPS (Diluted)	4.17	4.22	0.10	4.93	3.64
EPS (Diluted) Growth	-	1.13%	-97.69%	4,964.27%	-26.23%
Diluted Shares Outstanding	1.31B	1.28B	1.26B	1.26B	1.26B
EBITDA	10.54B	6.36B	11.92B	12.25B	12.86B
EBITDA Growth	-	-39.60%	87.37%	2.74%	4.97%
EBITDA Margin	-	-	-	-	47.48%	NA

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Gilead Sciences Inc.

Annual Financials for Gilead Sciences Inc.

Latest News

dow

nasdaq

s&p 500

Kiosk